With researchers around the world scrambling to find a way to tackle coronavirus using existing drugs, Bayer AG's 70-year-old antimalarial chloroquine has emerged as one of the most promising candidates but there are logistical issues that need to be overcome to getting hold of it.
There have been reports this week that Bayer is about to make a large amount of chloroquine to the US government for potential use, with the American news website, Axios, saying that its tip off came from "a senior US Health and Human Services official and another source with direct knowledge